$75.23
-1.14-1.49%
Last update: Nov 10, 4:00 PM
Globus Medical Inc
GMEDNYSE
Globus Medical fell 11.6% from $86.36 to $76.37, behind the S&P 500's +10.0%. Its worst day was Nov 6 (−12.8%), and its low came Nov 6 at $71.05.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $1.28 beat the $1.12 estimate on $826.4M revenue (est. $797.1M); FY revenue guidance of $3.2B–$3.2B against the $3.1B consensus.
+4.7% · S&P 500 +0.8%
Story events cover the past 12 months · Times ET
Globus Medical closed at its highest level of the year, 12.1% above where the year started.
+1.6% · S&P 500 −0.2%
EPS of $1.12 beat the $0.92 estimate on $759.9M revenue (est. $738.7M); FY revenue guidance of $3.2B–$3.2B against the $3.2B consensus.
−8.4% · S&P 500 +0.8%
EPS of $1.34 beat the $1.10 estimate on $789.6M revenue (est. $783.8M); FY revenue guidance of $3.2B–$3.2B against the $3.2B consensus.
+1.6% · S&P 500 +0.6%
EPS of $1.23 beat the $1.20 estimate on $763.7M revenue (est. $792.6M); FY revenue guidance of $3.1B against the $3.2B consensus.
−12.8%, the year's worst day, on 9M shares, the year's heaviest volume · S&P 500 +0.3%
Where it ended: a close of $76.37 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $1.30, revenue est. $802.5M).
Nothing in the past 12 months.
All GMED dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for GMED and SPY from Benzinga historical bars. Not investment advice.
